HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Hamadani Selected Research

Cyclophosphamide (Cytoxan)

10/2013Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Hamadani Research Topics

Disease

4Lymphoma (Lymphomas)
11/2017 - 08/2013
4Multiple Myeloma
01/2017 - 01/2012
4Neoplasms (Cancer)
11/2015 - 08/2013
3Hodgkin Disease (Hodgkin's Disease)
11/2015 - 05/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021 - 01/2017
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021 - 11/2015
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2016 - 08/2013
2Febrile Neutropenia
10/2013 - 04/2013
1Neutropenia
12/2021
1Thrombocytopenia (Thrombopenia)
12/2021
1Cardiovascular Diseases (Cardiovascular Disease)
02/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2017
1Virus Diseases (Viral Diseases)
12/2016
1Ulcer
02/2016
1Immunoglobulin Light-chain Amyloidosis
04/2015
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2013
1Second Primary Neoplasms (Neoplasms, Second)
08/2013
1Hematologic Neoplasms (Hematological Malignancy)
04/2013
1Bacteremia
04/2013
1Fever (Fevers)
04/2013
1Infections
02/2008
1Nocardia Infections
02/2008
1Coinfection
02/2008
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2007

Drug/Important Bio-Agent (IBA)

2Immunoconjugates (Immunoconjugate)IBA
12/2021 - 08/2013
2Biological ProductsIBA
11/2017 - 08/2013
2plerixaforFDA Link
04/2015 - 10/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2015 - 10/2013
2Anti-Bacterial Agents (Antibiotics)IBA
10/2013 - 04/2013
1loncastuximab tesirineIBA
12/2021
1TransferasesIBA
12/2021
1Tyrosine Kinase InhibitorsIBA
11/2017
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2015
1Immunologic Factors (Immunomodulators)IBA
11/2015
1Immune Checkpoint InhibitorsIBA
11/2015
1Proteasome InhibitorsIBA
11/2015
1Brentuximab VedotinIBA
11/2015
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2015
1Rituximab (Mabthera)FDA Link
11/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2013
1Monoclonal AntibodiesIBA
08/2013
1QuinolonesIBA
04/2013
1VancomycinFDA LinkGeneric
04/2013
1Lenalidomide (CC 5013)FDA Link
01/2012
1Bortezomib (Velcade)FDA Link
01/2012
1Thalidomide (Thalomid)FDA Link
01/2012
1NucleosidesIBA
02/2008
1Pentostatin (Nipent)FDA LinkGeneric
02/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2007

Therapy/Procedure

12Cell Transplantation
11/2017 - 04/2013
7Therapeutics
12/2021 - 01/2012
4Autologous Transplantation
01/2016 - 01/2012
2Transplantation
12/2016 - 08/2015
2Homologous Transplantation
02/2016 - 08/2013
1Immunotherapy
11/2017
1Drug Therapy (Chemotherapy)
12/2015
1Investigational Therapies (Experimental Therapy)
05/2014
1Hematopoietic Stem Cell Mobilization
10/2013
1Hematopoietic Stem Cell Transplantation
02/2008